We are delighted to announce that this article was published in the peer-reviewed journal, Advanced Research in Gastroenterology and Hepatology, Feb 16, 2018.
Here is the pdf of the published article
Epidemiologic studies show that IBD is prevalent in wealthy nations where dietary westernization usually occurs. Dietary westernization is characterized by increased consumption of animal protein, animal fat, and sugar. An epidemiological study found that the risk of Crohn’s disease reduced by 70% in females and 80% in males following a vegetarian diet.
Treatment with medications, though efficacious to a degree, all have significant adverse reactions. Many of these medications will also be contraindicated in a significant number of patients.
Treatment is aimed at inducing remission. A semi-vegetarian diet has been shown to achieve a 100% remission rate at 1 year and 92% at 2 years. Plant-based diets are rich in phytochemicals that help reduce inflammation by modifying several inflammatory mechanisms.
A study of treatment with infliximab and a plant-based diet showed a remission rate of 96%, substantial reduction in CRP and CDAI and improvements in mucosa healing. This study shows that combining infliximab with a plant-based diet results in a strong clinical response.
Plant-based diets promote a more favorable gut microbial profile that is anti-inflammatory. Naturally occurring substances in plant foods, having anti-inflammatory bowel actions include phytochemicals, antioxidants, dietary fibers, and lipids. Many of these natural products exert their beneficial action by altering cytokine production.
The plant-based diet has no adverse reactions or contra-indications and is affordable, so physicians can initiate therapy with a plant-based diet immediately, and prescribe it as a prophylaxis for all patients at risk of Crohn’s disease. Continue reading